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The objectives are to report the estimated prevalence of pregnancy complications and adverse 
pregnancy outcomes in a defined population of Alaska Native women and also examine factors 
contributing to an intensive and successful collaboration between a tribal health center and the 
Centers for Disease Control and Prevention. Investigators abstracted medical record data from a 
random sample of singleton deliveries to residents of the study region occurring between 1997 and 
2005. We used descriptive statistics to estimate the prevalence and 95 % confidence intervals of 
selected pregnancy complications and adverse pregnancy outcomes. Records were examined for 
505 pregnancies ending in a singleton delivery to 469 women. Pregnancy complication rates were 
5.9 % (95 % CI 4.0, 8.4) for gestational diabetes mellitus, 6.1 % (95 % CI 4.2, 8.6 %) for maternal 
chronic hypertension and 11.5 % (95 % CI 8.8, 14.6) for pregnancy associated hypertension, and 
22.9 % (95 % CI 19.2–26.5 %) for anemia. The cesarean section rate was 5.5 % (95 % CI 3.5, 7.5) 
and 3.8 % (95 % CI 2.3, 5.8) of newborns weighed >4,500 g. Few previous studies reported 
pregnancy outcomes among Alaska Native women in a specific geographic region of Alaska and 
regarding the health needs in this population. We highlight components of our collaboration that 
contributed to the success of the study. Studies focusing on special populations such as Alaska 
Native women are feasible and can provide important information on health indicators at the local 
level.
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Background
Although women of childbearing age and infants comprise approximately 46 % of Alaska’s 
native population [1], few population-based studies of the health status of Alaska Native 
women and infants have been conducted [2]. Furthermore, most existing studies combine all 
American Indian and Alaska Native women into one group, despite the fact that more than 
500 American Indian and Alaska Native tribes exist in the US, each with its own unique 
culture and traditions [3]. Tribal communities and health care providers, as well as local, 
state, and federal agencies often wish to obtain health information from a specific population 
for health planning purposes. Conducting health studies in remote areas can be challenging 
for a number of reasons, including time constraints imposed by grant requirements, expense 
associated with long-distance travel, and logistical difficulties associated with compiling 
population-based data for a particular ethnic group.
This secondary analysis used data from a random sample of pregnancies that served as a 
control group in an earlier case–control study of tobacco use and adverse pregnancy 
outcomes [4]. We report the estimated prevalence of pregnancy complications and adverse 
pregnancy outcomes in a defined population of Alaska Native women. We also examined 
factors contributing to an intensive and successful collaboration between a tribal health 
center and the Centers for Disease Control and Prevention (CDC). Our findings and 
recommendations can be used by community providers to inform clinical and public health 
programs for Alaska Native pregnant women and their offspring, as well as for women of 
reproductive age needing preconception care.
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Initial Community Generated Research Question
This study was initiated when local medical providers expressed concerns about potential 
adverse health effects of maternal smokeless tobacco use during pregnancy. In particular, 
some providers worried that use of smokeless tobacco might result in an increased risk of 
preeclampsia and/or placental abruption. CDC investigators met with local providers and 
tribal health center board members to discuss these concerns. Based on the high prevalence 
of tobacco use, availability of exposure data in the medical record, and severity of the 
outcomes of concern, both organizations agreed to jointly conduct a study of pregnancy 
outcomes in smokeless tobacco users. In addition, local medical center staff expressed an 
interest in the prevalence of these and other adverse outcomes in their community. The 
current analysis focuses on the latter topic. The collaborative research team included local, 
state, and CDC professionals.
Methodology Employed in Original Study
Study Region
The study region is in a remote area of western Alaska with a large indigenous population 
that is relatively homogenous with respect to socioeconomic status and culture. This region 
has its own health care system consisting of a single main outpatient and hospital facility 
and individual village clinics. The village clinics are staffed by lay health care workers who 
treat minor and some major illnesses based on clinical guidelines. Nearly all pregnant 
Alaska Native women in the study region (96 %) receive their health care through this 
system. Women from the study region who are experiencing pregnancy complications or 
who otherwise have high risk pregnancies are referred to the Alaska Native Medical Center 
in Anchorage (ANMC) or to Providence Alaska Medical Center in Anchorage (PAMC) for 
specialty care during pregnancy and/or for delivery. Of approximately 500 deliveries a year, 
<15 per year occur at home or in villages.
Study Population
Singleton deliveries were identified using discharge codes recorded in the regional hospital/
medical center’s and the Alaska Native Medical Center’s electronic Resource and Patient 
Management System (RPMS). The research team searched for hospitalizations of Alaska 
Native women residing in the study region with the International Classification of Diseases, 
9th Revision (ICD9-CM) discharge codes indicating delivery of an infant (liveborn or 
stillborn): any V27.0 or V27.1 or any 656.4 (intrauterine death after 22 weeks gestation). 
Because ICD9-CM code lists for hospitalizations are sometimes truncated, the following 
procedure codes were also used: 73.5, 74.0–74.2, 74.4, 74.99 (manually assisted delivery or 
cesarean section). Deliveries were excluded if the ICD9-CM codes indicated a multifetal 
gestation, including 651 (multiple gestation delivery, regardless of the 4th or 5th digit 
extension) or 652.61 (multiple gestation delivery with malpresentation of 1 or more fetus). 
Deliveries at PAMC to women residing in the study region were identified from hospital 
transfer records, as this hospital does not utilize the RPMS system.
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Process for Medical Record Abstractions and Data Entry
As previously described [4], the research team developed a study protocol, and created and 
piloted abstraction forms based on standard clinical and hospital forms used by the medical 
facilities. CDC staff held intensive training sessions with two chart abstractors (a nurse 
practitioner and a hospital data manager) at the beginning of the study and reviewed their 
completed abstraction forms several times throughout the study period to ensure that 
abstractors understood and adhered to abstraction procedures and that data were being 
abstracted from medical record sources in a consistent manner. CDC staff developed a data 
entry system using Epi Info and ensured that each data entry screen closely resembled the 
corresponding abstraction form page. Abstractors first examined medical records for all 
potential study deliveries to verify that they met inclusion criteria; deliveries were excluded 
if the mother was not a resident of the study region during the pregnancy of interest or was 
not Alaska Native, the pregnancy had more than one fetus, the delivery occurred before 22 
weeks’ gestation. In addition, we excluded any pregnancies indicating that the mother used 
alcohol in late pregnancy or used cocaine, amphetamines, or opioids at any time during 
pregnancy, or if the infant was born with a major congenital anomaly. Exact numbers of 
women excluded for prenatal drug exposure or congenital anomalies are not reported in 
order to protect the privacy of the study population and the community.
Once inclusion status was confirmed, additional data were abstracted from medical records, 
including: maternal demographic factors (age at delivery, marital status, highest level of 
education); gravidity; parity; trimester of prenatal care initiation; maternal height, 
prepregnancy weight, medical conditions (including type 1 or type 2 diabetes mellitus and 
chronic hypertension); tobacco exposure; birth weight; pregnancy complications [including 
gestational diabetes mellitus (GDM) and pregnancy associated hypertension (PAH)]; mode 
of delivery; and selected birth outcomes.
As part of routine data management procedures and to identify additional training needs to 
ensure data quality and accuracy, CDC investigators reviewed for accuracy abstracted data 
for 23 selected variables in approximately 10 % of the study deliveries. Each original 
response recorded on the abstraction form was reviewed to confirm that it could be verified 
in the medical record. Errors in abstractions were noted and then reviewed with the 
abstractors and, when necessary, retraining was provided. Frequent study meetings were 
held by phone to address questions about the abstraction process. The percentage of 
variables selected for review in which abstracted information could be verified ranged from 
88 to 100 %.
Dissemination of Findings
Once primary data were analyzed, the results and the study’s implications were presented to 
local providers and the hospital executive board and to perinatologists in Anchorage. During 
these presentations, local providers and board members gave input as to the implications of 
the findings. During the drafting of the manuscript, Alaska collaborators provided input as to 
the cultural appropriateness of the text. In addition, they provided feedback on the processes 
at the hospital and in the community. Based on the findings, local providers are now able to 
more accurately counsel patients about health risks, based on data from their own 
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community. Importantly, the study was able to provide data to providers to address their 
specific concerns and provides baseline data that can be used for many purposes, including 
resource planning and grant applications. The original case–control study has been 
published in a peer-reviewed journal [4].
Methodology for Current Secondary Analysis
Study Population
Our study population consisted of a population-based random sample of approximately 10 
% of all singleton deliveries to Alaska Native women who resided in the study region during 
pregnancy, used health care services at the regional hospital/medical center, and who 
delivered their infants at the regional hospital or referral hospital (ANMC or PAMC) 
between January 1, 1997 and December 31, 2005. As previously stated, data for this 
prevalence study came from a control population from a larger case–control study of 
pregnancy outcomes in smokeless tobacco users, previously described elsewhere [4].
Variables Included in Analysis
The research team classified maternal prepregnancy BMI using categories of the National 
Heart, Lung, and Blood Institute: <25 kg/m2 (underweight and normal), 25–29.9 
(overweight), 30–34.9 (class I obesity), 35–39.9 (class II obesity), and 40+ (class III 
obesity). High parity was defined as one or more previous births for adolescents (<18 years), 
3 or more previous births for 18–21 years, 4 or more previous births for 22–24 years, or 5 or 
more previous births for 25 and older [5]. Tobacco users were categorized into four mutually 
exclusive categories: tobacco non-users, cigarette smokers only, smokeless tobacco users 
only (iq’mik or commercial chew), or users of both cigarettes and smokeless tobacco. 
Iq’mik is a handmade mixture that includes leaf tobacco and ash from burned punk fungus, 
willow bush, or driftwood [6]. Pregnancies in which women quit using tobacco during 
pregnancy were categorized according to the type of tobacco used before cessation.
Maternal prenatal conditions included chronic diabetes, GDM, PAH, anemia, urinary tract 
infection (UTI), and pyelonephritis. Diabetes case definitions were as follows: GDM cases 
were identified using laboratory data and Carpenter-Coustan criteria [7]. We used physician 
or provider diagnosis of preexisting diabetes to identify chronic diabetes. Five mutually 
exclusive diabetes categories were developed: GDM, possible GDM (1-h screen was>140 
and an incomplete 3 h glucose tolerance test), chronic diabetes, no diabetes, and unknown. 
PAH was defined as clinician-diagnosed pregnancy induced hypertension, gestational 
hypertension, PAH, preeclampsia, eclampsia, or HELLP syndrome. Chronic hypertension 
was defined as clinician-diagnosed chronic hypertension, pregnancy induced hypertension 
superimposed on chronic hypertension, or preeclampsia superimposed on chronic 
hypertension. Anemia was defined as hemoglobin<10 g/dL during pregnancy.
Labor and delivery outcomes included cesarean delivery, polyhydraminos, oligohydramnios, 
fetal distress, and abruption; all were based on clinician diagnoses as recorded in the medical 
record. Adverse birth outcomes included shoulder dystocia, preterm delivery, admission into 
the neonatal intensive care unit, low birth weight, and macrosomia. We defined preterm 
delivery as delivery at <37 completed weeks gestation based on the provider’s estimated 
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date of confinement. Low birth weight was defined as birth weight<2,500 g. Macrosomia 
was defined both as birth weight >4,000 g and as birth weight >4,500 g.
Statistical Analysis
After limiting our study sample to the randomly-selected control group, we calculated the 
proportion of pregnancies with selected maternal characteristics, maternal medical 
conditions, and adverse birth outcomes with corresponding 95 % confidence intervals. We 
excluded pregnancies ending in a stillbirth or fetal death when calculating the percentage of 
pregnancies with adverse birth outcomes. Statistical analyses were performed using SAS 
software V.9 (SAS Institute Inc., Cary, NC) for Windows. The study proposal and data 
collection tools were reviewed and approved by the institutional review boards (IRBs) of the 
CDC and the Mayo Clinic, and by the Alaska Area IRB.
Results of Current Secondary Analysis
Our study sample included 505 pregnancies that ended in a singleton delivery to 469 
women. Less than 10 % of singleton pregnancies had substance abuse or congenital 
anomalies concerns and were excluded (n = 52). Of the 505 pregnancies, 61.4 % were to 
women between the ages of 20–29 years, 55.9 % were to women with a BMI ≥25 kg/m2, 
15.1 % were to women with a high parity-forage, 52.7 % were to women that were single, 
divorced, or widowed, 27.4 % were to women with less than a high school education, and 
75.5 % were to women who used some form of tobacco during pregnancy (mainly 
smokeless products) (Table 1) [4]. Notably, none of the pregnancies were complicated by 
preexisting diabetes, however 5.9 % (95 % CI 4.0, 8.4) of pregnancies were complicated by 
GDM based on the Carpenter and Coustan criteria (Table 2). Six percent (95 % CI 4.2, 8.6 
%) of pregnancies were complicated by maternal chronic hypertension and 11.5 % (95 % CI 
8.8, 14.6) by PAH. 23 % (95 % CI 19.2–26.5 %) of pregnancies were complicated by 
anemia, 5 % (95 % CI 3.5, 7.5) were delivered by cesarean and 3.6 % (95 % CI 2.2, 5.7) 
resulted in deliveries of newborns weighing >4,500 g.
Discussion
We describe the prevalence of pregnancy complications and adverse birth outcomes in a 
random sample of deliveries to Alaska Native women. Mothers in the study population were 
generally younger, multiparous, and less educated; had a higher BMI; and had higher use of 
tobacco than the general US and Alaska Native population [5, 8]. For example, we found 
that maternal overweight and obesity was present in approximately 56 % of pregnancies, 
compared to approximately 42 % reported in Alaska among Alaska Natives from the 
Pregnancy Risk Monitoring System in 2000 to 2003 [8]. Furthermore, in more than 70 % of 
pregnancies in the current study, women reported using some form of tobacco. These rates 
are much higher than published prenatal smoking prevalence estimates of 21.0 % for 
American Indian, 4.4 % for Hispanic, and 16.4 % for non-Hispanic white women from 1995 
to 2001 [5].
We found that while the prevalence estimates of some pregnancy complications and adverse 
birth outcomes were higher than the general population, others were not. GDM prevalence 
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was consistent with the range reported in multi-state analyses of women with a recent live 
birth [9]. The prevalence of cesarean deliveries in the study population was low compared to 
estimates reported in the literature on American Indians and Alaska Natives. This may 
reflect the fact that cesareans are not routinely performed in the local hospital.
In contrast, the estimates of the prevalence of hypertensive disorders were high in this 
population; 6.1 % had chronic hypertension and 11.5 % had PAH without underlying 
chronic hypertension. In a 1995–2001 US study comparing American Indians (including 
Aleuts and Eskimos) to Hispanics and non-Hispanic whites using live birth infant and death 
cohort files from 1995 to 2001, Alexander and colleagues found that the prevalence of all 
hypertensive disorders combined was 5.5 % for American Indians, 3.0 % for Hispanics, and 
4.5 % for non-Hispanic whites [5]. This discrepancy could reflect true difference in 
prevalence or that medical record reviews have higher sensitivity for ascertainment of 
pregnancy complications [10]. Public health interventions to address maternal tobacco use, 
obesity, and hypertension in this population, should be of high priority.
Key Factors Contributing to Study Success
A major strength of the current analysis is that the investigators were able to examine 
characteristics among Alaska Native women living in a defined region in western Alaska; 
unlike previous studies, this study did not combine Native populations. A number of factors 
were critical to the successful completion of this study. First, the investigators had access to 
a population-based, searchable hospital discharge data system (RPMS). This allowed for 
identification of nearly all deliveries among Alaska Native women living in this region 
during the study period. In addition, all deliveries except home births occurred in three main 
hospitals, making a complete population-based study design feasible. Because the study had 
strong local institutional support, the investigators had access to important resources, such as 
local medical record staff, facilities for reviewing records and convening meetings, and 
access to hospital staff for consultation and other types of support. The hospital/medical 
center was able to identify and hire local staff willing to be trained and to conduct medical 
record abstractions, and these employees stayed for the duration of the project. Computer 
and statistical programmers employed at local hospitals were available to provide assistance 
on site. The investigators also had access to a funding mechanism that provided sufficient 
flexibility to accommodate an extended timeframe. This was particularly important as this 
project required multiple institutional study protocol reviews, long-distance travel for 
development of study tools and abstractor training, and delays associated with staff absences 
due to seasonal activities such as fishing and hunting.
In this study, privacy concerns were especially important. In order to avoid inadvertently 
sharing sensitive information not directly related to the study topic, deliveries involving 
maternal alcohol or illicit substance use and deliveries of infants with congenital anomalies 
were excluded from data collection at the onset of the study. Strengths of the research staff 
that likely contributed to the study’s success included personal commitment, flexibility, and 
both organizations remaining open minded about the research process. CDC staff made on 
average 2–3 site visits a year and spent on average 2–3 h per week by phone providing 
technical and operational assistance. In addition, both organizations were willing to accept 
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multiple study modifications and to tolerate delays. Clear and consistent communication 
between staff in Alaska and CDC in Atlanta was important since continuous, on-site 
supervision of the chart abstraction process was not feasible. For example, the chart 
abstractors were very diligent in taking detailed notes regarding questions that come up 
during chart abstractions, so that CDC staff could help clarify these questions during regular 
conference calls. Finally, a major factor in the project’s success was the team’s commitment 
to giving careful consideration to varying points of view and to resolving conflicts in a 
mutually respectful manner.
Limitations
Our analysis has several limitations. As previously stated, this study only includes singleton 
deliveries among women who did not use alcohol in late pregnancy or illicit drugs at any 
time during pregnancy and who did not give birth to an infant with a major congenital 
anomaly. Thus our results cannot be generalized to all Alaska Native women in the study 
region. Our exclusions likely resulted in an underestimation of some adverse health 
outcomes, such as pre-term delivery and low birth weight. In addition, the size of our 
random sample was based on requirements for the main case control analysis and it was too 
small to generate stable estimates for rare outcomes such as meconium aspiration, placenta 
previa, sepsis, and very low birth weight. Therefore, these outcomes were not included in 
our analysis.
Conclusions
This descriptive analysis of maternal characteristics and pregnancy outcomes of Alaska 
Native women in a specific geographic region of Alaska provides unique information 
regarding health needs in this population. Common health problems in pregnant women in 
this community include a very high prevalence of smokeless tobacco use, chronic 
hypertension and obesity. Critical to the completion of this study were collaborative 
relationships between the government and local health care providers and the tribal health 
corporation. Local health center staff provided maximum input on study priorities, protocol 
development, and dissemination of findings. Future studies in remote areas focusing on 
unique populations such as Alaska Native women are feasible and can provide previously 
unavailable information on health indicators at the community level.
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Table 1
Maternal and prenatal care utilization characteristics of Alaska Native women in western Alaska, 1997–2005
Characteristic n % 95 % CI
Overall N 505 100
Maternal age (years)
 <20 65 12.9 10.1, 16.1
 20–29 310 61.4 57.0, 65.7
 30–39 117 23.2 19.6, 27.1
 40+ 13 2.6 1.4. 4.4
Maternal BMI (kg/m2)
 Lean/normal (<25) 187 44.1 39.3, 49.0
 Overweight (25–29.9) 127 30.0 25.6, 34.6
 Obese
  Class I (30–34.9) 61 14.4 11.2, 18.1
  Class II (35–39.9) 34 8.0 5.6, 11.0
  Class III (40+) 15 3.5 2.0, 5.8
Previous births
 0 115 22.9 19.3, 26.8
 1 118 23.5 19.8, 27.4
 2+ 270 53.7 49.2, 58.1
High paritya 76 15.1 12.1, 18.5
Marital status
 Married 226 47.3 42.7, 51.9
 Single/divorced/widow 252 52.7 48.1, 57.3
Education
 Less than high school 111 27.4 23.1, 32.0
 High school/general education development 245 60.5 55.5, 65.3
 Greater than high school 49 12.1 9.1, 15.7
Tobacco use during pregnancy
 Smoke only 87 17.3 14.1, 20.9
 Smokeless only 249 49.6 45.1, 54.1
 Both 43 8.6 6.3, 11.4
 None 123 24.5 6.3, 11.4
Trimester prenatal care initiation
 First 279 55.9 51.4, 60.3
 Second/third 220 44.1 39.7, 48.6
a
One or more previous births for adolescents (<18), 3 or more previous births for 18–21 years; 4 or more previous births for 22–24 years; 5 or 
more previous births for 25 and older
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Table 2
Maternal medical conditions and birth outcomes of Alaska Native women in western Alaska, 1997–2005
Characteristic n % 95 % CI
Maternal prenatal conditions
Preexisting diabetes mellitus 0 0
Gestational diabetes mellitus (GDM)
 No GDM 417 82.6 79.0, 85.8
 Possible GDM 28 5.5 3.7, 7.9
 GDM 30 5.9 4.0, 8.4
 Unknown 30 5.9 4.0, 8.4
Hypertension
 No Hypertension 416 82.4 78.8, 85.6
 Chronic Hypertension 31 6.1 4.2, 8.6
 Pregnancy associated hypertension 58 11.5 8.8, 14.6
Anemia 115 22.9 19.2–26.5
Urinary tract infection (UTI) 126 25.0 21.2, 29.0
Pyelonephritis 7 1.4 0.6, 2.8
Labor and delivery
 Cesarean section 28 5.5 3.5–7.5
 Polyhydramnios 9 1.8 0.6–2.9
 Oligohydramnios 11 2.2 0.9–3.5
 Fetal distress 20 4.0 2.3, 5.7
 Abruption 8 1.6 0.5–2.7
Birth Outcomesa
 Shoulder dystocia 18 3.6 2.2–5.7
 Preterm delivery 39 7.9 5.7–10.6
 Neonatal intensive care unit admission 23 4.6 2.9–6.8
 Low birth weight (<2,500 g) 13 2.6 1.4–4.4
 Macrosomia (>4,500 g) 18 3.6 2.2–5.7
 Macrosomia (>4,000 g) 117 23.6 20.0–27.6
a
Excludes pregnancies that ended in a stillbirth or fetal death
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